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Abstract 
Clinical phenotypes of spinocerebellar ataxia type-5 (SCA5) and spectrin-associated 
autosomal recessive cerebellar ataxia type-1 (SPARCA1) are mirrored in mice lacking β-III 
spectrin (β-III
-/-
). One function of β-III spectrin is the stabilisation of the Purkinje cell-specific 
glutamate transporter EAAT4 at the plasma membrane. In β-III-/- mice EAAT4 levels are 
reduced from an early age. In contrast levels of the predominant cerebellar glutamate 
transporter GLAST, expressed in Bergmann glia, only fall progressively from 3 months 
onwards.  Here we elucidated the roles of these two glutamate transporters in cerebellar 
pathogenesis mediated through loss of β-III spectrin function by studying EAAT4
 
and 
GLAST
 
knockout mice as well as crosses of both with β-III
-/-
 mice.  Our data demonstrate that 
EAAT4 loss, but not abnormal AMPA receptor composition, in young β-III-/- mice underlies 
early Purkinje cell hyper-excitability and that subsequent loss of GLAST, superimposed on 
the earlier deficiency of EAAT4, is responsible for Purkinje cell loss and progression of 
motor deficits. Yet the loss of GLAST appears to be independent of EAAT4 loss, highlighting 
that other aspects of Purkinje cell dysfunction underpin the pathogenic loss of GLAST. 
Finally our results demonstrate that Purkinje cells in the posterior cerebellum of β-III
-/-
 mice 
are most susceptible to the combined loss of EAAT4 and GLAST, with degeneration of 
proximal dendrites, the site of climbing fibre innervation, most pronounced. This highlights 
the necessity for efficient glutamate clearance from these regions and identifies dysregulation 
of glutamatergic neurotransmission particularly within the posterior cerebellum as a key 
mechanism in SCA5 and SPARCA1 pathogenesis.   
 
Introduction 
Output from the cerebellar cortex sculpts fine control of motor movements and balance and is 
derived solely from Purkinje cell neurons, alterations to which result in ataxia.  Cerebellar 
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abnormalities may also underlie pathophysiology in Alzheimer’s disease (1,2), schizophrenia 
(3), autism (4-6) and other cognitive and neuropsychiatric disorders (7-10).  
Mutations in the gene encoding β-III spectrin (SPTBN2) lead to spinocerebellar ataxia 
type-5 (SCA5) (11) and spectrin-associated autosomal recessive cerebellar ataxia type-1 
(SPARCA1) (12), two human neurodegenerative diseases involving gait ataxia and cerebellar 
atrophy. β-III spectrin is highly expressed in the cerebellum and the phenotype of β-III
-/-
 
mutant mice mirrors the clinical phenotypes of SCA5 and SPARCA1 (12,13). Considerable 
Purkinje cell dysfunction is detectable in young β-III-/- mutant mice prior to cell loss, 
including increased parallel fibre-Purkinje cell excitatory postsynaptic currents (PF-PC 
EPSCs) and a 50% reduction in EAAT4 protein levels (13). A progressive loss of GLAST is 
also seen from 3 months of age (13).  EAAT4 and GLAST are the two principal cerebellar 
glutamate transporters, and ultrastructural analysis of Purkinje cells from β-III-/- mice 
revealing dark cell degeneration is consistent with cell death occurring from delayed 
glutamate-mediated excitotoxicity (13).  
We previously demonstrated that β-III spectrin directly interacts with EAAT4 and 
stabilises high levels of expression at the plasma membrane (14).  The early loss of EAAT4 in 
β-III-/- mice is, therefore, almost certainly due to loss of the β-III spectrin anchor. However, 
the cellular and molecular mechanisms responsible for the delayed loss of GLAST in β-III
-/-
 
mice is still to be resolved. The present study uses crosses of ET4
-/-
 and GLAST
-/-
 knockout 
mice with β-III
-/-
 mice to dissect the relative roles of these glutamate transporters in the 
pathophysiology of motor deficits. We used these genetic approaches to determine the 
mechanisms underlying initial hyper-excitability in β-III-/- Purkinje cells (13) and identify 
which factors previously only correlated with ataxia are directly linked to disease, facilitating 
the development of effective therapeutic strategies.  
Here we demonstrate that loss of EAAT4 accounts for the initial hyper-excitability of 
Purkinje cells lacking β-III spectrin and that loss of GLAST appears to work synergistically 
to worsen motor deficits. Yet the early loss of EAAT4 does not underlie the subsequent loss 
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of GLAST protein.  When levels of both EAAT4 and GLAST are compromised in β-III
-/-
 
mice, the proximal dendrites of Purkinje cells within the posterior cerebellum are the most 
vulnerable to degeneration. This highlights the importance of efficient glutamate clearance in 
the vicinity of climbing fibre innervation and identifies this region as an important therapeutic 
target for SCAs.    
 
Results 
EAAT4 loss results in Purkinje cell hyper-excitability similar to β-III-/- mice 
To discern differences in glutamatergic neurotransmission and investigate the involvement of 
EAAT4 loss in the previously reported β-III-/- Purkinje cell hyper-excitability (13) we 
measured PF-mediated EPSC amplitudes at increasing stimulus intensities, as widely reported 
(15-18). This revealed that PF-EPSCs in 6–week old EAAT4 knockout (ET4-/-) mice were 
significantly larger at all stimulus intensities compared to wild type (WT) (p = 1.9 x 10
-5
 
Figure 1A), similar to β-III
-/-
 mice (13). Moreover, there was no significant difference in 
amplitude between ET4-/- cells and β-III-/-/ET4-/- cells (p = 0.646) indicating EAAT4 loss 
underpins the enhanced PF-PC EPSC amplitudes observed in β-III
-/-
 mice (13).  
To ascertain whether the increased EPSC amplitudes were a consequence of pre- or 
post-synaptic effects paired-pulse facilitation was measured by evoking two presynaptic 
spikes in close succession (Figure 1B). This provides an indication of the release probability 
of the pre-synaptic cell by comparing the postsynaptic response of the second spike to the first 
spike. No difference in the paired-pulse facilitation ratio was seen between 6-week old WT, 
ET4-/- and β-III-/-/ET4-/- mice demonstrating changes in presynaptic release probability from 
parallel fibre terminals are unlikely to underlie the enhanced EPSC amplitudes in ET4-/- and 
β-III
-/-
/ET4
-/-
 mice (Figure 1B). Examination of the decay kinetics revealed the single 
exponential decay time constant of WT Purkinje cells was similar to the study by Watase et 
al. (19) for mature Purkinje cells (14.3 ± 3.8 (SD)) and no difference was detected between 
WT, ET4-/- and β-III-/-/ET4-/- animals (Figure 1C). In contrast the decay kinetics in GLAST-/- 
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mice had a single exponential decay time constant 36% longer than WT mice (p = 0.018; data 
not shown). This is in agreement with other studies (20,21), and further validates our PF-
EPSC data. 
 
No difference in AMPA receptor composition in β-III
-/-
 mice 
During normal development in the cortex and hippocampus the composition of AMPA 
receptors changes, with calcium permeable GluA1-containing receptors present early in 
development being replaced during maturation by calcium impermeable GluA2-containing 
receptors (22,23). Failure to switch from GluA1 to GluA2, or to edit GluA2 subunits would 
result in persistent expression of Ca2+-permeable AMPA receptors and EPSCs with larger 
amplitudes (24-27). Similarly, in the cerebellum it has been reported that by P30 GluA1 is no 
longer expressed in neurons and is exclusively expressed in Bergmann glia (28). Therefore to 
determine whether an abnormal AMPA receptor composition is involved in the enhanced PF-
PC EPSC amplitudes observed in Purkinje cells from β-III-/- mice we carried out whole-cell 
voltage-clamp recordings from 3-week old animals. Inward rectification, a characteristic of 
receptors lacking GluA2, due to their voltage-dependent block by intracellular polyamines 
was not observed for either genotype at 3-weeks of age (Figure 2A,B). In addition, equivalent 
abundance and cellular distribution of GluA1 immunoreactivity was observed in the 
molecular layer of β-III-/- animals when compared to wild type animals (Pearson’s correlation 
coefficient (R ± SEM) for GluA1 colocalization: with GFAP P7, WT 0.78 ± 0.55,  β-III
-/-
 0.77 
± 0.54; P14, WT 0.75 ± 0.53, β-III-/- 0.77 ± 0.55; with calbindin P7, WT 0.82 ± 0.58,  β-III-/- 
0.81 ± 0.57; P14, WT 0.8 ± 0.46, β-III
-/-
 0.81 ± 0.47; Figure 2C). Together these data reveal 
no difference in the expression profile of GluA1 in β-III-/- animals, with normal edited 
GluA2-containing receptor compositions in mature β-III
-/-
 Purkinje cells.   
 
Loss of GLAST accentuates motor deficits in young β-III
-/-
 animals 
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Since a progressive loss of GLAST protein was found to correlate with worsening motor 
deficits and Purkinje cell loss in β-III
-/-
 animals (13) we investigated whether loss of GLAST 
is instrumental in disease progression. This was achieved by carrying out the first longitudinal 
behaviour analysis of GLAST knockout mice using gait analysis, rotarod and an elevated 
beam task.  
There was no difference in hind-limb base width (p = 0.618; Figure 3A), number of 
slips off the elevated beam (p = 0.907; Figure 3B) or ability to stay on rotarod at 3- and 5-rpm 
(Figure 3C) in 6- week old GLAST
-/-
 animals when compared to age-matched WT animals.  
The main significant deficit observed in young GLAST-/- animals, compared to age matched 
WT mice, is their ability to remain on the rotarod at 10-rpm (p = 0.035, 0.046, 0.039, 0.025, 
trial 1-4 respectively; Figure 3C). However it may be that young GLAST
-/-
 animals are 
slightly poorer at learning motor tasks than WT animals shown by a potential learning deficit 
at 3 rpm (Figure 3C). By 6-months of age GLAST-/- animals have a significantly wider hind-
limb base width than when they were 6-weeks old (p= 0.01; Figure 3A) and wider than 6-
month old WT animals (p = 0.004). They make a greater number of slips on the elevated 
beam when 6-months old compared to age-matched WT (p = 0.003; Figure 3B) and to when 
they were 6-weeks old (p= 0.002). Finally by 7.5-months of age they are worse on the rotarod 
at 3-rpm on day 1 and 2 of testing (p = 0.035, 0.008 respectively) and never attain WT 
performance level, on any day of testing at 10 months of age (p = 0.02, 0.0002, 0.005, 0.0002; 
Figure 3D).   
Moreover analyses of young β-III
-/-
/ GLAST
+/-
 animals, arising from crossing 
GLAST-/-  animals with β-III-/- mice, revealed a worse performance on the rotarod at 3 –rpm 
compared to age-matched WT, β-III
-/-
, GLAST
-/-
 and β-III
-/-
/ET4
-/-
 animals (p = 7.73 x 10
-6
, 
0.013, 8.55 x 10-7, 0.004; Figure 4A). Similarly young β-III-/-/GLAST+/- animals had a 
significantly wider hindlimb base width (p = 7.6 x 10-6, 1.4 x 10-5, 2.5 x 10-4, 4 x 10-4; Figure 
4B) and made more slips on an elevated beam (p = 1.1 x 10
-5
, 3.8 x 10
-4
, 8.82 x 10
-7
, 0.01; 
Figure 4C) than WT, β-III
-/-
, GLAST
-/-
 and β-III
-/-
/ET4
-/-
 mice, respectively. There was also a 
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significant difference in motor phenotype of young β-III
-/-
/ GLAST
+/-
 animals to both young 
EAAT4
+/-
 and GLAST
+/-
 animals (data not shown).  Finally confocal immunofluorescence 
microscopy confirmed levels of GLAST protein in young β-III
-/-
/ GLAST
+/-
 animals were 
similar to that of GLAST+/- animals (Figure 4D). Comparison of double mutant β-III-/-
/GLAST
-/- 
animals was prevented due to non-Mendelian offspring genotypes arising from 
genetic crosses and therefore an insufficient number of animals with this genotype were 
obtained. 
In contrast no difference was observed between the motor phenotype of young β-III
-/-
 
and β-III-/-/ET4-/- mice using rotarod (p = 0.999; Figure 4A), hindlimb base width (p = 0.963; 
Figure 4B) and elevated beam (p = 0.974; Figure 4C) analyses. Moreover hindlimb base 
width measurements in 1-year old animals indicated a similar disease progression in β-III-/-
/ET4
-/-
 mice (3.1 ± 0.17 cm) to that of β-III
-/-
 animals (3.12 ± 0.11 cm, p = 0.919)  but an 
exacerbated phenotype in β-III-/-/GLAST+/- animals (3.63 ± 0.13 cm, p = 0.005).   
Together this behavioural data clearly illustrates for the first time that loss of GLAST 
results in a progressive ataxic phenotype and it provides the first direct evidence that a 
reduction in GLAST protein levels acts in synergy with loss-of β-III spectrin function to 
accentuate motor decline, and is not simply an inconsequential side effect. 
 
Loss of GLAST accelerates Purkinje cell loss in young β-III-/- animals 
To determine whether loss of GLAST is also a key factor in the death of β-III-/- Purkinje cells 
we examined Purkinje cell density in the posterior cerebellum of 3-month old β-III
-/-
/GLAST+/- mice. The posterior cerebellum was chosen for this temporal analysis as even at 1-
year of age in β-III-/- mice we observe no significant loss of Purkinje cells within the anterior 
cerebellum compared to WT (p = 0.996; Figure 5A,B) whereas significant cell death is 
evident in the posterior cerebellum when compared to WT (p = 0.029) and to the anterior 
cerebellum of β-III
-/-
 mice (p = 0.039). Quantification revealed there was cell loss in 3-month 
old β-III-/-/GLAST+/- mice compared to age-matched WT animals (p = 0.035), whereas no 
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significant loss was observed for either β-III
-/-
 or GLAST
-/-
 animals (p = 0.835, 0.970; Figure 
5C,D). These results again demonstrate a synergistic effect of reduced GLAST levels and 
loss-of β-III spectrin function resulting in diminished Purkinje cell survival. We see no 
Purkinje cell loss in either EAAT4+/- or GLAST+/- animals (data not shown). 
 
Loss of GLAST is not a downstream consequence of early EAAT4 loss  
The mechanism for loss of GLAST protein in β-III-/- mice is not known but thought to be 
dependent on Purkinje cell dysfunction; immunofluorescence studies within the cerebellum 
have so far only shown β-III spectrin to be expressed in Purkinje cells (13, 29). To ascertain 
whether there is any expression of β-III spectrin in Bergmann glia, and there is a cell-
autonomous effect of β-III spectrin loss on GLAST protein levels, we carried out semi-
quantitative RT-PCR and immunoblot analysis using extracts from primary cerebellar glial 
cultures and total cerebellar homogenates. No β-III spectrin transcript (Figure 6A) or protein 
(Figure 6B) was detected in primary cerebellar glial cultures, the purity of which was 
confirmed by the low level of GLT1 protein expression (Figure 6B), also an astroglial 
glutamate transporter but the expression of which is highly-dependent on the co-culturing 
with neurons (30-32).  These results indicate that β-III spectrin is unlikely to be expressed in 
Bergmann glia in vivo and demonstrate that in β-III-/- animals a non-cell autonomous effect 
most likely underlies loss of GLAST in Bergmann glia. 
To determine whether the later loss of GLAST is a downstream consequence of 
earlier EAAT4 loss from Purkinje cells, possibly mediated by excessive activation of 
Bergmann glial AMPA receptors (33), we examined GLAST levels in 6-month old ET4-/- 
mice by immunoblot analyses. No loss was detected compared to WT animals (p = 0.38; 
Figure 6C). Furthermore when compared to β-III-/- animals no additional loss of GLAST 
protein was observed in 6-month old β-III
-/-
/ET4
-/-
 mice (p = 0.84), corroborating the same 
rate of disease progression observed in β-III-/- and β-III-/-/ET4-/- animals (Figure 4). Since the 
spectrin-based cytoskeleton has a multitude of functions mediated by interactions with 
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various proteins (34, 35) additional downstream consequences of loss-of β-III spectrin 
function in synaptic and structural integrity likely underpin the subsequent loss of GLAST in 
Bergmann glia. 
  
Dendritic degeneration in β-III-/- animals is greater in posterior Purkinje cells with 
proximal dendrites being the most susceptible 
Finally to investigate further the regional difference in Purkinje cell death in β-III-/- mice 
(Figure 5) we filled, by diffusion from a whole-cell patch pipette, individual Purkinje cells in 
acute cerebellar sagittal slices with a fluorescent dye. Cells were visualized by confocal 
microscopy and the dendritic surface area of individual Purkinje cells measured from anterior 
(lobules II, III, IV, V) and posterior (VIII, IX, X) lobules (Figure 7A). This revealed in 6-
month old animals a significant difference in the extent of dendritic degeneration between β-
III
-/-
 Purkinje cells from posterior and anterior lobules (p = 0.05) and between posterior β-III
-/-
 
and WT cells (p = 0.006) but not between anterior β-III-/- and WT cells (p = 0.248; Figure 
7B,C). However by 1-year of age there is a significant difference in dendritic surface area 
between β-III
-/-
 and WT cells from anterior lobules (60.9 ± 4.9 % of WT, p = 0.025, N = 5, n 
= 7 (WT), 9 (β-III-/-) and further degeneration of β-III-/- cells from posterior lobules [35.6 ± 6 
% of WT, p = 1.5 x 10-5, N = 5, n = 12 (WT), 9 (β-III-/-)]. 
Images of individually filled Purkinje cells were also used to measure the distance 
from cell body to first branch point and this revealed that in animals  > 6-months of age this 
distance was significantly larger in β-III-/- cells from posterior lobules compared to WT cells 
(p = 4.0 x 10
-5
) and β-III
-/-
 cells in anterior lobules (p = 2.4 x 10
-7
). However there was no 
difference in distance from cell body to first branch point between WT and β-III-/- cells in 
anterior lobules (p = 0.988; Figure 7B,D). The absence of proximal dendrites in β-III
-/-
 
Purkinje cells from posterior lobules was not a developmental defect as they were present in 
6-week old β-III
-/-
 mice (Figure 7E). Moreover some Purkinje cells (3 out of 9 cells) in 
anterior lobules exhibited some loss of proximal dendrites at 18-months of age highlighting a 
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progression of proximal dendritic degeneration (Figure 7F).  Together the data reveal that 
proximal dendrites are the most susceptible to degeneration, starting within the posterior 
cerebellum but progressing to the anterior cerebellum, identifying a novel feature of disease 
pathology (Figure 8).  
Finally we previously reported that in acute slices the spontaneous activity of β-III-/- 
Purkinje cells was about half that of WT cells, both at 6-weeks and 6-months of age (13). 
However, within this study no distinction was made between posterior and anterior lobules. In 
light of our current observation that the degeneration of posterior β-III-/- Purkinje cells is 
earlier and greater than that of anterior Purkinje cells we sought to determine whether there 
was any variation in the reduction of spontaneous activity in the different populations of β-III-
/- Purkinje cells. No significant difference in frequency was observed within the different 
populations in young or old β-III-/- animals (Figure 7G) and a similar regularity of firing was 
observed in all populations (coefficient of variation < 0.2). Nevertheless it was cells in 
anterior lobules from 6-week old β-III
-/-
 mice, those exhibiting the least amount of 
degeneration, that were found to have the highest spontaneous activity and therefore the 
closest to that of age-matched WT cells (41.7 ± 4.6 Hz, 0.02 ± 0.003 s).  
 
Discussion 
This study conclusively demonstrates that loss of EAAT4 underpins early Purkinje cell hyper-
excitability in β-III-/- animals and is the first study to directly show that loss of GLAST 
accentuates motor deficits and Purkinje cell death, appearing to act in synergy with loss-of β-
III spectrin function. Moreover the posterior cerebellum appears to be especially vulnerable to 
the synergistic effect, likely involving the combined loss of functional EAAT4 and GLAST 
(Figure 8). Yet, the observed loss of GLAST in β-III
-/-
 animals does not appear to arise from 
the earlier loss of EAAT4 protein.  
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Loss of β-III spectrin leads to complete loss of functional EAAT4 resulting in Purkinje 
cell hyper-excitability  
Several studies, including our own, have shown EAAT4 levels to be reduced early in various 
mouse models of ataxia (13, 36-38). For example we observed loss of EAAT4 in β-III
-/-
 mice, 
a mouse model of SCA5/SPARCA1, before any Purkinje cell degeneration (13). Similarly 
reduced EAAT4 levels were observed in young Spnb3-/- mice, another mouse model of SCA5, 
with EAAT4 accumulating in the cell soma and dendritic shafts (38), a feature reported in 
SCA5 autopsy tissue (11). Loss of EAAT4 was also found in a mouse model of 
spinocerebellar ataxia type I (SCA1) prior to any sign of disease (36,39) and EAAT4 levels 
were found to be decreased in a spontaneous mouse model (staggerer) of ataxia  (37). These 
correlative findings have long suggested that EAAT4 loss may play a key role in ataxia but 
direct evidence corroborating this association has been lacking.  
Here, using EAAT4 knockout mice, we have shown that the greater excitation we 
observe in young β-III
-/-
 mice is due to loss of EAAT4. A similar increase in peak amplitude 
of PFPC-EPSCs was observed in young ET4-/- mice as seen in β-III-/- mice (13) and moreover 
there was no additive effect in β-III
-/-
/ET4
-/- 
mice when compared to ET4
-/- 
and β-III
-/-
 mice. 
Together these data provide compelling evidence that the greater excitation arising from loss-
of β-III spectrin function is due to loss of EAAT4 and reduced post-synaptic glutamate 
uptake. Moreover despite β-III-/- mice still expressing about 50% of WT EAAT4 protein 
levels the increase in Purkinje cell excitability is the same for ET4
-/- 
and β-III
-/-
 animals. There 
is also no difference in motor phenotype between β-III-/- and β-III-/-/ET4-/- mice. It would 
therefore appear that in the absence of β-III spectrin the remaining EAAT4 protein is not 
functional. This is an important finding as it suggests that even if levels of EAAT4 could be 
elevated pharmacologically or through genetic re-introduction it would be unlikely to lead to 
any therapeutic benefit as without the β-III spectrin anchor the EAAT4 protein would not be 
correctly targeted or maintained at the plasma membrane. 
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Our observed change in peak amplitude of PFPC-EPSCs in ET4-/- mice is in contrast 
to two earlier studies (40, 41). However, the animals used in each study were of different 
ages; Nikkuni et al using 18-22 day old mice (41), Takayusu et al 22-42 day old (40), while 
the present study used 42-46 day old mice. Furthermore differences in recording conditions 
(temperature and holding potential) between the three studies also hinders direct comparison 
and could account for variations in observations. In addition the varying molecular 
composition of Purkinje cells from different sagittal compartments (42-44) has the possibility 
of further compounding variability between different data sets.  
 
Loss of β-III
 
spectrin and GLAST act in synergy to exacerbate motor decline  
Similar to EAAT4, correlative findings have also suggested loss of GLAST may play a role in 
the progression of ataxia, but again direct evidence has been lacking. Correlative findings 
include loss of GLAST and reduced astroglial glutamate uptake when mutant ataxin-7 is 
solely expressed in Bergmann glia with this mouse displaying ataxia and Purkinje cell death 
(45). Further correlative evidence comes from conditional ablation of Bergmann glia in adult 
mice resulting in ataxia and degeneration of Purkinje cell dendrites (46) and loss of GLAST 
observed in mouse models of SCA1 (47) and SCA5 (13) at later stages of disease.  
 We have carried out the first longitudinal study using GLAST knockout mice and 
have shown that loss of GLAST gives rise to progressive ataxia. Previously it had been 
reported that GLAST deficient mice display mild motor deficits, but the age of mice was not 
reported (19). Here we show a mild motor defect in young (6-weeks of age) GLAST-/- 
animals but reveal that the motor deficits are progressive, with old animals performing much 
worse on all motor tasks. Moreover through genetic crosses we directly show for the first time 
that reducing GLAST levels has a severe consequence on the severity of ataxia in β-III
-/-
 
animals with young β-III-/-/GLAST+/- mice displaying a much earlier decline in motor 
performance than either β-III
-/-
 or GLAST
-/-
 animals highlighting a synergistic effect of 
reduced GLAST and loss-of β-III spectrin function, likely due to a combined loss of EAAT4 
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and GLAST, the two predominant glutamate transporters in the cerebellum. This conclusion 
is supported by our analysis of young EAAT4-/-/ GLAST-/- double knockouts that show the 
same level of motor dysfunction as β-III-/-/GLAST+/- mice (data not shown). 
 
Survival of β-III-/- Purkinje cells in posterior cerebellum dependent on high levels of 
both EAAT4 and GLAST  
The fact loss of Purkinje cells was observed within the posterior cerebellum of young 
β-III-/-/GLAST+/- and old β-III-/- animals indicates that these cells are particularly vulnerable 
to the synergistic effect of loss of GLAST and β-III spectrin function. GLAST is believed to 
be present in functional excess throughout the cerebellum (48). In contrast EAAT4 displays a 
differential pattern of expression within parasagittal bands with Purkinje cells in posterior 
regions possessing higher levels of EAAT4 compared to anterior regions of the cerebellum 
(42,44,49). It is therefore Purkinje cells that should normally express high levels of EAAT4 
that appear to be most vulnerable to the combined loss of GLAST and β-III spectrin (hence 
EAAT4). Of note greater glutamate release was shown to occur from climbing fibre terminals 
in zebrin-positive regions, zones of high EAAT4 expressing Purkinje cells (50). Purkinje cell 
proximal dendrites, the site of climbing fibre innervation, in the posterior cerebellum may 
therefore be the most susceptible to degeneration following the combined loss of the two 
predominant glutamate transporters, EAAT4 and GLAST due to higher levels of glutamate 
exposure. It is yet to be determined if differences in functional circuitry between zebrin-
positive and negative bands underlie the selective progressive Purkinje cell susceptibility. 
 There is no significant difference in the reduction of spontaneous firing rate between 
β-III-/- Purkinje cells with varying extents of cell degeneration. This finding indicates that 
there is no effect of cell atrophy on reduced voltage-gated sodium channel density following 
loss of β-III spectrin function (13, 51), in contrast to a reported compensatory effect of 
neuronal atrophy in a mouse model of SCA1 which restored BK channel density and intrinsic 
membrane excitability (52).  
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The molecular mechanism leading to the later but progressive loss of GLAST in β-III
-
/-
 mice is unclear. Identifying this mechanism will be paramount in the development of an 
effective therapy since data from this study directly highlights the critical role loss of GLAST 
plays in disease progression. 
 
Relevance of posterior cerebellar pathology 
The discovery that the posterior cerebellum is the first area affected pathologically in β-III
-/-
 
mice provides additional insight into disease pathogenesis and possibly the specific cognitive 
deficits observed following complete loss of β-III spectrin function (12). Although there are 
anatomical differences between mice and humans with respect to cerebellar input and 
involvement of cerebellum in non-motor functions (53), if the human posterior cerebellum is 
similarly more vulnerable to loss of both EAAT4 and GLAST the functional connectivity 
between the prefrontal cortex and posterior cerebellum (54,55) would be disrupted in 
SPARCA1 patients. Of note the posterior cerebellar-prefrontal circuit is involved in cognitive 
tasks such as attention shifting and verbal working memory tasks (56,57) which appear to be 
especially impaired in patients with ataxia (58).  
In addition the prefrontal cortex and the posterior cerebellum are believed to be 
significantly affected by ageing (59-61). The discovery that Purkinje cells within the posterior 
cerebellum are more sensitive to reduced levels of both EAAT4 and GLAST protein may also 
provide mechanistic insight into age-related decline in motor and cognitive ability. 
Developing therapeutic strategies to target the posterior cerebellum is likely to prove useful 
not only in alleviating motor and cognitive deficits associated with inherited ataxias but may 
also mitigate effects of normal ageing. 
 
Materials and Methods 
Animals. All procedures involved in generation and analysis of mutant mice were carried out 
according to the United Kingdom Animals (Scientific Procedures) Act (1986) and other 
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Home Office regulations under specific-pathogen-free conditions. GLAST
-/-
, ET4
-/-
 and β-III
-/-
 
mice, all on a C57BL/6 genetic background, were generated as described previously 
(13,19,43) and both sexes were used in all experiments. The genotypes of all experimental 
animals were confirmed by PCR analysis on genomic DNA extracted from ear notch biopsies 
using ChargeSwitch gDNA tissue kit (Invitrogen, Carlsbad, CA) as described previously (13) 
or as follows: for ET4
-/-
 mice a common upstream primer (5'-ttcctgattgctggaaagattctgg-3') and 
primers specific for the wild-type allele (5'-agttcagggaaaggccataccttgg-3') and the PGK-neo 
cassette in the mutant allele (5'-ggatcggccattgaacaagatgg-3') were used for amplification. The 
220-bp (from wild-type allele) and 1200-bp (from targeted allele) PCR products were 
resolved by electrophoresis on a 1.6 % w/v agarose gel. For GLAST-/- mice specific primer 
sets were used for amplification of wild-type allele (5'-aagtgcctatccagtccaacga-3'; 5'-
aagaactctctcagcgcttgcc-3') and mutant allele (5'-aatggaaggattggagctacgg-3'; 5'-
ttccagttgaaggctcctgtgg-3'). The 214-bp (from wild-type allele) and 362-bp (from targeted 
allele) PCR products were resolved by electrophoresis on a 1.6 % w/v agarose gel.   All 
knockout mice were viable although pups from GLAST-/- mice were routinely fostered with 
CD1 mothers to ensure survival.  
   Slice electrophysiology. PF-EPSC measurements at a range of stimuli (3-18 V, 200 µs 
duration) were recorded at room temperature as previously described (13) and the amplitudes 
and decay time constants (tau) of PF-evoked EPSCs measured using the NeuroMatic analysis 
program in IGOR Pro (Wavemetrics, Lake Oswergo, OR). Spontaneous action potentials 
from acute slices were recorded at 30˚C ± 2˚C as previously described (13). Sagittal 
cerebellar slices (200 µm) from P16-21 WT and β-III-/- mice were used to determine I/V 
relationship of PF-EPSCs. Internal solution contained (in mM): 108 Cs Methanesulfonate, 9 
NaCl, 9 HEPES, 1.8 EGTA, 1.8 MgCl2, 0.4 NaGTP, 2 MgATP, 63 sucrose and 5 QX-314, 
adjusted to pH 7.4 with CsOH. Recordings were made at room temperature and picrotoxin 
(50 µM) was added to the ACSF. Stimulus intensity was set to evoke PF-EPSCs of 
approximately 500 pA at Vh -60 mV (7-42 V, 200 µs). Spermine (0.1 mM) was included in 
 at Edinburgh U
niversity on A
ugust 23, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
16 
 
the internal solution to replace dialysed endogenous polyamines. I/V relationships for PF-
EPSCs in WT and β-III
-/-
 mice were generated by averaging 3 EPSCs at each holding 
potential (-80 mV to +60 mV in 20 mV increments).  Series resistances were <15 MΩ and 
were compensated for by 85%. Data was acquired using pClamp 9 (Molecular Devices, 
Sunnyvale, CA) and recordings were filtered at 2 kHz and sampled at 10 kHz. Data analysis 
was carried out in Neuromatic, IGOR Pro (Wavemetrics, Lake Oswego, OR) and using in-
house MatLab scripts. 
   Motor coordination tests. Elevated beam, footprint analysis and rotarod were performed as 
previously described (13). 
   Immunohistochemistry. Brains were removed and immersion-fixed with 4% w/v 
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4 overnight at 4°C and either 
embedded in paraffin or cryoprotected by immersion in 0.1 M sodium phosphate buffer (pH 
7.4) containing 30% w/v sucrose.  Paraffin sections (10 µm-thick), mounted on poly-L-lysine 
coated slides, were immunostained with anti-GluA1 antibody (Abcam). All other tissue was 
quick-frozen on dry-ice, then 30 µm-thick coronal free-floating cerebellar sections 
immunostained with either anti-calbindin (Swant) or anti-GLAST antibody as described 
previously (62). All quantification, carried out blind to genotype, involved counting the 
number of Purkinje cells in anterior (lobules I-V, simplex and crus I) and posterior cerebellum 
(lobules VI -IX, crus II and flocculonodular lobe, lobule X) from three sections/animal and 
the counts averaged. Data was pooled from GLAST
-/-
 and β-III
+/-
/GLAST
-/-
 animals as no 
phenotype observed in β-III
+/-
 animals (62). Images were captured with either a Zeiss inverted 
LSM510 or Nikon confocal laser scanning microscope and co-localisation analysis carried out 
using Image J. 
   Cerebellar astrocyte culture. Primary astrocytes were purified from 6-day old WT mouse 
cerebella. The cerebella were dissected and incubated in papain for 30 min at 37°C. After 
trituration in astrocyte media (DMEM high glucose, 2 mM glutamine, 10% v/v FBS) 
containing 0.02% w/v DNase cells were preplated for 20 min on an uncoated dish to remove 
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contaminant fibroblasts. Unattached cells were transferred to a dish coated with 0.5 µg/ml of 
poly-D-Lysine for 1 h to allow astroglial attachment. Cells were rinsed with PBS to remove 
neurons and were cultured in DMEM with 10% v/v FBS. Cultures were passaged after 2-3 
DIV. 
      Semiquantitative RT-PCR. Total RNA was extracted from mouse cerebellum or primary 
glial cultures using RNeasy Mini kit (Qiagen, Valencia, CA) and RT-PCRs carried out using 
One-Step RT-PCR kit (Qiagen) according to manufacturer’s instructions.  Primers for RT-
PCR reactions were: β-III spectrin F1 5'-atgagcagcactctgtcacccact-3', R7 5'-
gccaattcttttgccttccacagc-3'; GLAST For  5'-atgacaaaaagcaacggagaag-3', Rev 5'-
ctacatcttggtttcgctgtc-3'. Amplification of the ubiquitously expressed elongation factor alpha 
was used to control for RNA levels (Stratagene, La Jolla, CA). 
   Immunoblotting. Protein extracts were prepared from whole cerebella or primary glial 
cultures and processed as previously described (13). Primary antibodies were goat anti-βIII 
spectrin (1:1000; Santa Cruz), rabbit anti-GLAST (1:200), -GLT1 (1:4,000) or mouse anti-
actin, -calbindin (1:1,600; Sigma, St. Louis, MO). Secondary antibodies were HRP-
conjugated donkey anti-rabbit IgG, HRP-conjugated sheep anti-mouse IgG (1:4,000; 
Amersham Pharmacia) and HRP-conjugated donkey anti-goat IgG (1:4,000; Santa Cruz). 
   Purkinje cell filling. Individual Purkinje cells were filled with 0.02 mM Alexa FluorAR 568 
hydrazide (Invitrogen, A-10441) and imaged as described previously (29). Surface area was 
quantified using in-house MatLab scripts and distance to first branch point measured on z-
projections in Image J.  
   Statistics. EPSC data were analysed using a mixed model ANOVA with post-hoc Tukey’s 
HSD for between subjects comparisons.  All other data was assessed either by Kruskal-Wallis 
or ANOVA followed by Bonferroni-corrected Mann-Whitney and Tukey’s HSD post-hoc 
tests, respectively. Significance was accepted at p-values of 0.05 or less. N = number of 
animals and n = number of cells.  
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Figure 1. Larger parallel fibre-mediated EPSC amplitude in ET4-/- mice A, Top, 
representative EPSC waveforms at 6 V stimulus and immunoblot analysis for all genotypes. 
Bottom, mean PF-PC EPSC amplitudes versus stimulus intensity for 6-week old WT, ET4
-/-
 
and β-III
-/-
/ET4
-/-
 animals. No significant differences detected between ET4
-/-
 and β-III
-/-
/ET4
-
/-
 across the range of stimulus intensities but both significantly different to WT animals using 
mixed model ANOVA analysis B, Top, examples of PF-EPSC waveforms for pairs of stimuli 
at 6 V. Bottom, degree of paired-pulse facilitation. C, Single exponential decay time 
constants. All data are means ± SEM, N = 3-5, n = 11 (β-III-/-/ET4-/-), 13 (WT) and 15 (ET4-/-
). 
 
Figure 2. No change in GluA1-containing AMPA receptors in young βIII-/- Purkinje cells. A, 
Superimposed synaptic currents evoked at various holding potentials (-80 to +60 mV; 20 mV 
increments). B, Current-voltage relationship for EPSCs recorded from Purkinje cells with 
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spermine in patch pipette. All data are means ± SEM, N = 3, n = 7 (WT) and 4 (βIII
-/-
). C, 
Midline sagittal cerebellar sections from animals at postnatal day 7 and 14, immunostained 
with anti-GluA1 antibody. Bar, 50 µm, N = 3 for both genotypes.  
 
Figure 3. Progressive motor impairment in GLAST
-/- 
mice. A, Hind limb base width of 6-
week and 6-month old animals. B, Number of hind-limb slips 6-week and 6-month old mice 
made when crossing narrow, elevated beam. C, Latency of 6-week old animals to fall from 
rotarod at 3-, 5- and 10-rpm.  D, Latency of 7.5- and 10- month old WT and GLAST
-/- 
animals 
to fall from rotarod at 3-rpm. All data are means ± SEM. N = 14 (WT), 14 (young GLAST-/-), 
7 (old GLAST
-/-
) in all panels. E, Immunoblot analyses of cerebellar homogenates from 6-
week old WT, GLAST
+/-
 and GLAST
-/-
 animals. 
 
Figure 4. Motor decline of βIII-/- animals accelerated by additional early loss of GLAST A, 
Latency of 6- week old mice to fall from rotarod at 3-rpm. B, Hind limb base width of 6-week 
old animals. C, Number of hind-limb slips 6-week old mice made when crossing narrow, 
elevated beam. All data are means ± SEM, N = 14 (WT), 7 (βIII-/-), 14 (GLAST-/-), 8 (βIII-/-
/GLAST
+/-
), 8 (βIII
-/-
/ET4
-/-
). D, Coronal sections of posterior cerebellum from 2-month old 
mice immunostained with anti-GLAST antibody. Bar, 50 µm. 
 
Figure 5. Purkinje cell loss in posterior lobules of βIII-/- mice accelerated by additional early 
loss of GLAST. A, Coronal cerebellar sections from 1-year old WT and βIII
-/- 
mice 
immunostained with anti-calbindin antibody. B, Quantification of Purkinje cell density in 1-
year old WT and βIII
-/-
 mice.  C, Representative confocal images, from coronal sections, of 
lobules VIII and IX from 3-month old mice immunostained with anti-calbindin antibody. D, 
Quantification of mean Purkinje cell density in lobules VIII, IX, X and Crus II of 
hemispheres. All data are means ± SEM, N = 3 for each genotype. Bar, 50 µm. 
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Figure 6. EAAT4 loss does not result in loss of GLAST. A, Semi-quantitative RT-PCR 
analysis for βIII-spectrin and GLAST using RNA template extracted from cerebellar tissue 
(crb) or primary glial cultures (glia). Amplification of elongation factor (EF1A1) controlled 
for total template levels. B, Immunoblot analysis of 10 µg of cerebellar and primary glial 
culture homogenate (arrow, full length (FL) βIII-spectrin, lower MW bands degradation 
products). C, Top, Immunoblot analyses of cerebellar homogenate from 6-month old WT, 
ET4-/-, βIII-/- and βIII-/-/ET4-/- animals. Bottom, Densitometry data quantifying GLAST 
protein levels, normalised to actin and expressed as percentage of WT levels. N = 4 for each 
genotype. All data are means ± SEM. 
 
Figure 7. Proximal dendrites of posterior βIII
-/- 
Purkinje cells most vulnerable to dendritic 
degeneration. A, Schematic of sagittal section of cerebellar lobules.  B, Representative 
confocal images of Purkinje cells filled with Alexa Fluor 568 from anterior (II –V) and 
posterior (VIII-X) lobules of 6-month and 1-year old WT and βIII
-/-
 animals. C, 
Quantification of dendritic surface area of individual Purkinje cells from 6-month old WT and 
βIII
-/-
 mice. N = 3, n = 4 (WT), 6 (βIII
-/-
) for each region. D, Quantification of distance from 
Purkinje cell soma to first dendritic branch point in animals > 6-months of age. N = 9, n = 14 
(WT), 18 (βIII
-/-
). E, Representative confocal images of Purkinje cells filled with Alexa Fluor 
568 from posterior (VIII-X) lobules of 6-week old WT and βIII-/- animals. F, Representative 
confocal images of Purkinje cells filled with Alexa Fluor 568 from anterior lobules (II –V) of 
18-month old WT and βIII-/- animals. G, Spontaneous firing frequency and interspike interval 
of Purkinje cells from young [N= 4, n = 12 (anterior), 19 (posterior)] and old βIII
-/-
 animals 
[N = 9, n =28 (anterior), 30 (posterior)]. All data are means ± SEM. Bar, 20 µm.  
 
Figure 8. Differences in the timeline of degeneration between anterior and posterior 
cerebellar lobules in a mouse model of SCA5/SPARCA1 
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